Furthermore, the authors reported significant inconsistency between the frequentist approach (results described above) and the Bayesian fixed-effect model, in which the latter revealed no difference in the risk of HF comparing DPP-4 inhibitors to GLP-1 agonists (HR, 1.21; 95% CI 0.91, 1.58). This evidence concerns the gene GCG and hydrops fetalis.